Loading...

PT Kalbe Farma Tbk.

PTKFY•PNK
Healthcare
Drug Manufacturers - General
$10.25
$-0.24(-2.31%)
U.S. Market opens in NaNh NaNm

PT Kalbe Farma Tbk. (PTKFY) Stock Overview

Explore PT Kalbe Farma Tbk.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap11.6M
P/E Ratio10.88
EPS (TTM)$0.93
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$15.07
3 Months$11.49
1 Year Target$8.13

PTKFY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of PT Kalbe Farma Tbk. (PTKFY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 33.49, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $8.13.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.88 and a market capitalization of 11.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.31%
5-Day Change
-6.39%
1-Month Change
1.49%
3-Month Change
-28.32%
6-Month Change
-29.89%
Year-to-Date (YTD) Change
-24.07%
1-Year Change
-35.94%
3-Year Change
-64.62%
5-Year Change
-49.73%
All-Time (Max) Change
-44.65%

Contact Information

https://www.kalbe.co.id
62 21 4287 3888
Gedung KALBE, Jakarta, NaN, 10510

Company Facts

12,841 Employees
IPO DateAug 13, 2012
CountryID
Actively Trading

Frequently Asked Questions